These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 33128490)

  • 21. Remdesivir for coronavirus disease 2019 (COVID-19): a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials.
    Okoli GN; Rabbani R; Copstein L; Al-Juboori A; Askin N; Abou-Setta AM
    Infect Dis (Lond); 2021 Sep; 53(9):691-699. PubMed ID: 33974479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical studies assessing the efficacy, effectiveness and safety of remdesivir in management of COVID-19: A scoping review.
    Pimentel J; Laurie C; Cockcroft A; Andersson N
    Br J Clin Pharmacol; 2021 Jul; 87(7):2663-2684. PubMed ID: 33245577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence.
    Lin HXJ; Cho S; Meyyur Aravamudan V; Sanda HY; Palraj R; Molton JS; Venkatachalam I
    Infection; 2021 Jun; 49(3):401-410. PubMed ID: 33389708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS-CoV-2 infection - a single-center, retrospective, cohort study.
    Kautsch K; Wiśniowska J; Friedman-Gruszczyńska J; Buda P
    Eur J Pediatr; 2024 Feb; 183(2):591-598. PubMed ID: 37864601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the role of remdesivir in patients with COVID-19?
    Beigel JH
    Curr Opin Crit Care; 2021 Oct; 27(5):487-492. PubMed ID: 34353998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.
    Terzić V; Miantezila Basilua J; Billard N; de Gastines L; Belhadi D; Fougerou-Leurent C; Peiffer-Smadja N; Mercier N; Delmas C; Ferrane A; Dechanet A; Poissy J; Espérou H; Ader F; Hites M; Andrejak C; Greil R; Paiva JA; Staub T; Tacconelli E; Burdet C; Costagliola D; Mentré F; Yazdanpanah Y; Diallo A;
    Clin Infect Dis; 2024 Aug; 79(2):382-391. PubMed ID: 38552208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy.
    Russo P; Tacconelli E; Olimpieri PP; Celant S; Colatrella A; Tomassini L; Palù G
    Viruses; 2022 May; 14(6):. PubMed ID: 35746668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness.
    Mechineni A; Kassab H; Manickam R
    Expert Opin Drug Saf; 2021 Nov; 20(11):1299-1307. PubMed ID: 34338121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
    Cantini F; Goletti D; Petrone L; Najafi Fard S; Niccoli L; Foti R
    Drugs; 2020 Dec; 80(18):1929-1946. PubMed ID: 33068263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
    Tasavon Gholamhoseini M; Yazdi-Feyzabadi V; Goudarzi R; Mehrolhassani MH
    J Pharm Pharm Sci; 2021; 24():237-245. PubMed ID: 34048669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Meta-Analysis of Safety of Different Regimens of Remdesivir in COVID-19 Patients.
    Konwar M; Maurya M; Bose D
    Curr Drug Saf; 2022; 17(2):158-167. PubMed ID: 34323191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
    Gottlieb RL; Vaca CE; Paredes R; Mera J; Webb BJ; Perez G; Oguchi G; Ryan P; Nielsen BU; Brown M; Hidalgo A; Sachdeva Y; Mittal S; Osiyemi O; Skarbinski J; Juneja K; Hyland RH; Osinusi A; Chen S; Camus G; Abdelghany M; Davies S; Behenna-Renton N; Duff F; Marty FM; Katz MJ; Ginde AA; Brown SM; Schiffer JT; Hill JA;
    N Engl J Med; 2022 Jan; 386(4):305-315. PubMed ID: 34937145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-World Effectiveness of Remdesivir in Adults Hospitalized With Coronavirus Disease 2019 (COVID-19): A Retrospective, Multicenter Comparative Effectiveness Study.
    Garibaldi BT; Wang K; Robinson ML; Betz J; Caleb Alexander G; Andersen KM; Joseph CS; Mehta HB; Korwek K; Sands KE; Fisher AM; Bollinger RC; Xu Y
    Clin Infect Dis; 2022 Aug; 75(1):e516-e524. PubMed ID: 34910128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment.
    Chang MC; Wu PF; Ho YC; Lin WY; Wu CY; Liu SY; Liu CJ; Lin YT
    J Infect Public Health; 2024 Jul; 17(7):102460. PubMed ID: 38820894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: A case-control study.
    Boglione L; Dodaro V; Meli G; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Borrè S
    J Med Virol; 2022 Aug; 94(8):3653-3660. PubMed ID: 35411627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of remdesivir for patients with Covid-19: a review article.
    Azevedo TCP; Azevedo PCP; Silveira Filho RN; Carvalho ARVS; Cezarotti Filho ML; Barbosa FT; Sousa-Rodrigues CF; Matos-Rocha TJ; Ramos FWDS
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):838-841. PubMed ID: 32696862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remdesivir: A Closer Look at Its Effect in COVID-19 Pandemic.
    Taha HR; Keewan N; Slati F; Al-Sawalha NA
    Pharmacology; 2021; 106(9-10):462-468. PubMed ID: 34515227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compassionate Use of Remdesivir in Children With Severe COVID-19.
    Goldman DL; Aldrich ML; Hagmann SHF; Bamford A; Camacho-Gonzalez A; Lapadula G; Lee P; Bonfanti P; Carter CC; Zhao Y; Telep L; Pikora C; Naik S; Marshall N; Katsarolis I; Das M; DeZure A; Desai P; Cao H; Chokkalingam AP; Osinusi A; Brainard DM; Méndez-Echevarría A
    Pediatrics; 2021 May; 147(5):. PubMed ID: 33883243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis.
    Wang M; Wu T; Zuo Z; You Y; Yang X; Pan L; Hu Y; Luo X; Jiang L; Xia Z; Deng M
    BMJ Support Palliat Care; 2021 Mar; 11(1):45-52. PubMed ID: 32958501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remdesivir for severe covid-19: a clinical practice guideline.
    Rochwerg B; Agarwal A; Zeng L; Leo YS; Appiah JA; Agoritsas T; Bartoszko J; Brignardello-Petersen R; Ergan B; Ge L; Geduld H; Gershengorn HB; Manai H; Huang M; Lamontagne F; Kanda S; Kawano-Dourado L; Kurian L; Kwizera A; Murthy S; Qadir N; Siemieniuk R; Silvestre MA; Vandvik PO; Ye Z; Zeraatkar D; Guyatt G
    BMJ; 2020 Jul; 370():m2924. PubMed ID: 32732352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.